Decoy Therapeutics Inc
(DCOY)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,273 | 4,373 | 5,900 | 7,581 | 11,541 |
| Receivables | N/A | N/A | N/A | N/A | 130 |
| TOTAL | $3,514 | $4,830 | $6,520 | $8,324 | $11,956 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 40 | 53 | 67 | 80 | 99 |
| TOTAL | $40 | $53 | $67 | $80 | $99 |
| Total Assets | $3,554 | $4,884 | $6,587 | $8,404 | $12,055 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 643 | 714 | 603 | 1,089 | 2,287 |
| Accrued Expenses | 535 | 403 | 407 | 773 | 1,354 |
| TOTAL | $1,179 | $1,234 | $1,299 | $2,321 | $3,642 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,179 | $1,234 | $1,299 | $2,321 | $3,642 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 96 | 40 | 36 | 33 | 30 |
| Retained earnings | -79,488 | -78,063 | -76,348 | -75,466 | -73,023 |
| TOTAL | $2,375 | $3,650 | $5,287 | $6,084 | $8,414 |
| Total Liabilities And Equity | $3,554 | $4,884 | $6,587 | $8,404 | $12,055 |